Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-19

Clinical Trial Update: Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment [Phase 4]

View source ↗

Summary

Phase 4 pragmatic trial comparing vortioxetine to SSRIs in elderly patients with major depressive disorder; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (vortioxetine)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED